Scan4Safety: Where Does the Value Really Sit?

Introduction

Scan4Safety is often introduced through a compelling proposition: more reliable identification of products used in patient care, with the possibility of safer processes and more efficient use of resources. Its economics, however, cannot be reduced to the cost of a scanner or the promise of lower stock levels. They reach into working capital, clinical time, product availability, information quality and the recurring cost of maintaining a service that works every day.

That distinction matters to a trust considering a new investment. The question is not simply whether Scan4Safety can produce benefits; published NHS experience shows that it can. The more demanding commercial question is which benefits are likely to be realised in a particular organisation, over what period and against which continuing commitments.

An encouraging evidence base, with different kinds of value

The original six NHS Scan4Safety demonstrator trusts reported approximately 140,000 clinical hours released to patient care, almost £5 million of recurrent inventory savings and £9 million in non-recurrent inventory reductions over the programme. These are three different outcomes. Time made available to clinicians is not automatically a reduction in payroll expenditure; a reduction in inventory held on the balance sheet is not the same as a recurring saving in annual operating costs.¹

Later reporting has broadened the evidence. In September 2026, GS1 UK published research developed with The PSC, drawing on 29 healthcare organisations in the UK and Ireland and national cost data. Its scenario modelling suggested that extending inventory management and point-of-care scanning in the relevant…